This application seeks continuing funding for the Cancer Center Support Grant (CCSG) of the University of Chicago Cancer Research (UCCRC), now in its thirteenth year of operation. Since its establishment in 1973, the UCCRC has built or renovated 50,000 square feet and submitted 18 program grants which were approved and funded. In the period 1973-1989, over $39 million National Cancer Institute (NCI) awards for programs and building/renovation will have been made; during the same period, institutional commitment will be over $30 million. Current (10/31/85) annual sponsored programs in cancer research and training total $12.7 million with $10.7 million from NCI and other federal agencies. Over 90 members participate in four program areas: Viral Oncology, Cancer Biology and Carcinogenesis, Cancer Immunology, Clinical-Laboratory Cancer Research. There are four approved program grants: Viral Oncology Program Grant, Etiology of Treatment-Induced Secondary Leukemia Program Grant, Immunity and Cancer Program Grant, and Clinical-Laboratory Studies in Gynecologic Cancer Program Grant. A renovation program is currently under way which will permit major recruitment in basic science as well as in clinical cancer research areas. The funds sought in this application will support (1) the Professional Personnel consisting of the Director and Deputy Director, (2) The Administrative Office of the UCCRC, (3) the Planning and Evaluation functions, (4) the Viral Oncology Core Facility, (5) the Erman Core Laboratory in Cancer Biology, (6) the High Resolution NMR Spectroscopy and Mass Spectrometry Cancer Research Facility, (7) the Biostatistical and Data Management Core Facility, (8) the Oligopeptide Synthesis Core Facility, (9) The Animal Barrier Core Facility, and (10) New Investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-14
Application #
3101434
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1977-02-01
Project End
1992-01-31
Budget Start
1987-02-01
Budget End
1988-01-31
Support Year
14
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Zeineddine, Hussein A; Girard, Romuald; Saadat, Laleh et al. (2018) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest :
Kane, Melissa; Deiss, Felicity; Chervonsky, Alexander et al. (2018) A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses. J Virol 92:
Xiao, Annie; Crosby, Jennie; Malin, Martha et al. (2018) Single-institution report of setup margins of voluntary deep-inspiration breath-hold (DIBH) whole breast radiotherapy implemented with real-time surface imaging. J Appl Clin Med Phys 19:205-213
Gamazon, Eric R; Trendowski, Matthew R; Wen, Yujia et al. (2018) Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Sci Rep 8:733
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Pu, Jinyue; Kentala, Kaitlin; Dickinson, Bryan C (2018) Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. ACS Chem Biol 13:431-437
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898

Showing the most recent 10 out of 668 publications